Sophia Genetics SA (STU:90B)
€ 4.82 +0.080 (+1.69%) Market Cap: 407.39 Mil Enterprise Value: 404.79 Mil PE Ratio: 0 PB Ratio: 8.69 GF Score: 50/100

SOPHiA GENETICS SA at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 03:30PM GMT
Release Date Price: €3.64 (-6.19%)
Daniel Brennan
Cowen and Company LLC - Analyst

Welcome, Dan Brennan here. Day three of the TD Cowen Global Healthcare Conference, 46th annual. I think it's my fifth one right now. really pleased to join you on stage with the management team of SOPHiA GENETICS. To my immediate left, we've got Ross Muken, who will be assuming the CEO role come this summer. To his left, we have Jurgi Camblong, who's CEO and co-founder. Kellen Sanger is in the audience as well. Listen, gentlemen, thank you for being here.

Jurgi Camblong
SOPHiA GENETICS SA - Chief Executive Officer, Co-Founder, Director

Thank you.

Questions & Answers

Daniel Brennan
Cowen and Company LLC - Analyst

Maybe we could start. We'll kick it back and forth between both of you, but maybe we'll start with Jurgi. It was announced back in January you're gonna transition to executive chairman, will also be promoted from president to CEO effective July 1st. Maybe take a moment to reflect upon the business you built co-founding it 15 years ago, and kinda why

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot